Mercator MedicalSTU:MM2 -1.43%54 Net Margin % is 9.04% as of Mar. 2026, which is 166% above its 10-year median of 3.40. GuruFocus rates STU:MM2 with a GF Score™ of 54/100 and a GF Value™ of €11.54. The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Mercator Medical ranks worse than 50.06% on this metric.
The historical rank and industry rank for Mercator Medical's Net Margin % or its related term are showing as below:
STU:MM2'
s Net Margin % Range Over the Past 10 Years
Min: -34.95 Med: 3.4 Max: 50.71
Current: 2.09
STU:MM2's Net Margin % is ranked worse than 50.06% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs STU:MM2: 2.09
Mercator Medical (STU:MM2) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Mercator Medical Net Margin % Related Terms
Mercator Medical Net Margin % Historical Data
* Premium members only.
The historical data trend for Mercator Medical's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:MM2 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Mercator Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercator Medical Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's Net Margin % distribution charts can be found below:
* The bar in red indicates where Mercator Medical's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercator Medical (STU:MM2) has a Net Margin % of 9.04% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Mercator Medical and its competitors. This is 166% above median its historical median of 3.40. According to the industry distribution chart, Mercator Medical ranks #409 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Mercator Medical's Net Margin % too high?
Mercator Medical's current Net Margin % of 9.04% is 166% above median its 10-year median of 3.40. The Medical Devices & Instruments industry median Net Margin % is 2.09. Mercator Medical's value of 9.04% is 332.5% above this industry median. Based on the distribution chart, Mercator Medical ranks #409 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Mercator Medical has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #409 out of 817 companies for Net Margin %. This places Mercator Medical in the lower half of its industry. The industry median Net Margin % is 2.09. Mercator Medical's value of 9.04% is 332.5% above this benchmark. While the company's 10-year median is 3.40 vs. the industry median of 2.09, Mercator Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current Net Margin % of 9.04% is 332.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Mercator Medical and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current Net Margin % is 9.04%, which is 166% above median its own 10-year median of 3.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Mercator Medical (STU:MM2) has a current Net Margin % of 9.04%. The stock's GF Value™ is €11.54, compared to a current price of €11.04 — trading 4.3% below its estimated fair value. The current Net Margin % is 9.04%, which is 166% above median its 10-year median of 3.40 and 332.5% above the Medical Devices & Instruments industry median of 2.09. Mercator Medical's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Mercator Medical (STU:MM2), the current Net Margin % is 9.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercator Medical (STU:MM2) Overvalued in 2026?
Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued.
The current stock price of €11.04 is trading 4.3% below its estimated GF Value™ of €11.54.
Key valuation signals for STU:MM2:
Net Margin %: 9.04% (166% above median its 10-year median of 3.40)
GF Value™: €11.54 vs. price of €11.04 (4.3% below fair value)
Industry Position: 332.5% above the Medical Devices & Instruments median (#409 of 817)
No single metric tells the full story. See the STU:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
54GF Score
Get the complete analysis for STU:MM2
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MM2 has been successfully added to your 
